Collaboration efforts aim to reduce manual burden of adverse event [...]

Eyam Health, a Canadian biotech, teams with Medicines for Malaria [...]

Neuraxpharm Group, a leading European specialty pharmaceutical company focused on [...]

Scancell has reported updated results from its Phase 2 SCOPE [...]

The US Food and Drug Administration’s (FDA) decision to phase [...]

The National Institute for Health and Care Excellence (NICE) has [...]

Corteria Pharmaceuticals has launched a Phase 2 trial of its [...]

Sanofi has agreed to acquire Vicebio Ltd, a biotechnology company [...]

A Yorkshire-based company is quietly transforming how pharmaceutical and clinical [...]

The pharmaceutical sector is accelerating into an enterprise-scale AI future, [...]